Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has acquired Organon, a pharmacy business in the healthcare sector, in an announced merger acquisition. Sun Pharma acquisitions focus on expanding pharmaceutical capabilities and product portfolios, while Organon operates in women’s health and specialty medicines. The Sun Pharma acquisition of Organon supports strategic acquisition goals across healthcare M&A by strengthening branded drug offerings and pipeline execution. The strategic acquisition is structured as a merger acquisition, with deal size undisclosed, and is expected to close subject to customary approvals and conditions.